Screener
Cronos Group CRON Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Net revenue by Product | ||||||
| Cannabis extracts | $13.77M+64.8% | $11.46M+33.1% | $10.77M+63.4% | $9.96M+27.9% | $8.36M+18.3% | |
| Cannabis flower | $39.21M+56.7% | $33.73M+44.5% | $33.75M+44.2% | $26.36M+0.1% | $25.03M+21.1% | |
| Net revenue by Geography | ||||||
| Canada | $28.71M+49.9% | $25.35M+25.9% | $27.92M+42.0% | $23.13M-3.9% | $19.15M-3.5% | |
| Israel | $15.02M+60.2% | $14.15M+53.3% | $11.84M+51.7% | $11.35M+56.4% | $9.38M+36.1% | |
| Other countries | $9.28M+88.3% | $5.71M+96.6% | $4.78M+68.0% | $1.85M-36.9% | $4.93M+379% |
FAQ
- How does Cronos Group break its business down?
- Cronos Group (CRON) reports net revenue by product across 2 parts — Cannabis extracts and Cannabis flower. Each is extracted from the segment footnotes and tracked over time.
- Where does Cronos Group's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Cronos Group's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
